Company intelligence / Profile preview

Accexible

Barcelona, Catalonia, Spainaccexible.com ↗

Ownership: Private
Development stage: Commercial

Overview

Accexible has developed and commercialized an AI-powered speech analysis platform that enables early detection and monitoring of cognitive impairments such as dementia and Parkinson’s. The technology has been validated in clinical settings but does not follow traditional drug clinical trial stages. Pipeline_breadth and pipeline fields are less applicable as the company offers a single core technology/platform rather than multiple therapeutic programs.

Therapeutic areas: CardiovascularNeurology
Modalities: Non-pharmacological therapy
Industry: Digital Health Medical Devices

Partnerships

EIT Health/EIT Supernovas mentoring network participation

Beyond the preview

Go deeper on Accexible.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Accexible.

Explore the full profile